Search in:

Advanced search

Scandinavian Journal of Urology and Nephrology Volume 37, 2003 - Issue 3

Submit an article Journal homepage

Views

CrossRef citations to date

Altmetric

Urology: Clinical research: ORIGINAL ARTICLE

Does Initial Surveillance in Early Prostate Cancer Reduce the Chance of Cure by Radical Prostatectomy?: A Case-Control Study

Ali KhatamiFrom the Departments of Urology, Sahlgrenska Universitetssjukhuset, Göteborg, SwedenCorrespondence[email protected]

Jan-Erik DamberFrom the Departments of Urology, Sahlgrenska Universitetssjukhuset, Göteborg, Sweden

Pär LoddingFrom the Departments of Urology, Sahlgrenska Universitetssjukhuset, Göteborg, Sweden

Carl-Gustaf PihlFrom the Departments of Pathology, Sahlgrenska Universitetssjukhuset, Göteborg, Sweden

Jonas HugossonFrom the Departments of Urology, Sahlgrenska Universitetssjukhuset, Göteborg, Sweden

Pages 213-217 | Received 28 May 2002, Accepted 06 Nov 2002, Published online: 24 Feb 2021

Cite this article
https://doi.org/10.1080/00365590310008073

References
Citations
Metrics
Reprints & Permissions

REFERENCES

Walsh PC, Partin AW. Treatment of early stage prostate cancer: radical prostatectomy. Important Adv Oncol 1994: 211-23.
Google Scholar
Wallner K, Roy J. Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol 1996; 14: 449-53.
PubMed Web of Science ®Google Scholar
Stone NN, Stock RG. Prostate brachytherapy: treatment strategies. J Urol 1999; 162: 421-6.
PubMed Web of Science ®Google Scholar
Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA, et al. Radiation therapy for clinically localized prostate cancer. A multi-institutional pooled analysis. JAMA 1999; 281: 1598-604.
PubMed Web of Science ®Google Scholar
Bolla M, Gonzales D, Warde P, Dubois JB, Mirimanoff RO, Storme G, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and Goserelin. N Engl J Med 1997; 337: 295-300.
PubMed Web of Science ®Google Scholar
Adolfsson J. Deferred treatment of low grade stage T3 prostate cancer without distant métastasés. J Urol 1993; 149: 326-8, discussion 328-9.
PubMed Web of Science ®Google Scholar
Whitmore WF Jr. Expectant management of localized prostate cancer. Cancer 1991; 67: 1091-6.
PubMed Web of Science ®Google Scholar
Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995; 274: 626-31.
PubMed Web of Science ®Google Scholar
Andriole GL, Catalona WJ. The diagnosis and treatment of prostate cancer. Annu Rev Med 1991; 42: 9-15.
PubMed Web of Science ®Google Scholar
Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993; 71 (3 Suppl): 933-8.
PubMed Web of Science ®Google Scholar
Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tic) prostate cancer. JAMA 1994; 271: 368-74.
PubMed Web of Science ®Google Scholar
Lundberg S, Berge T. Prostatic carcinoma. An autopsy study. Scand J Urol Nephrol 1970; 4: 93-7.
PubMedGoogle Scholar
Franks LM. The incidence of carcinoma of prostate: an epidemiological survey. Recent Results Cancer Res 1972; 39: 149-55.
PubMedGoogle Scholar
Boccon-Gibod L. Significant versus insignificant prostate cancer—can we identify the tigers from the pussy cats? J Urol 1996; 156: 1069-70.
PubMed Web of Science ®Google Scholar
Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 1993; 149: 1478-81.
PubMed Web of Science ®Google Scholar
Epstein JI, Walsh PC, Carter HB. Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage Tic disease. J Urol 2001; 166: 1688-91.
PubMed Web of Science ®Google Scholar
Carter HB, Walsh PC, Landis P, Epstein JI. Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. J Urol 2002; 167: 1231-4.
PubMed Web of Science ®Google Scholar
Epstein JI, Partin AW, Sauvageot J, Walsh PC. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with longterm follow-up. Am J Surg Pathol 1996; 20: 286-92.
PubMed Web of Science ®Google Scholar
McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Capsular penetration in prostate cancer. Significance for natural history and treatment. Am J Surg Pathol 1990; 14: 240-7.
PubMed Web of Science ®Google Scholar
Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999; 281: 1395-400.
PubMed Web of Science ®Google Scholar
Adolfsson J, Ronstrom L, Lowhagen T, Carstensen J, Hedlund PO. Deferred treatment of clinically localized low grade prostate cancer: the experience from a prospective series at the Karolinska Hospital. J Urol 1994; 152: 1757-60.
PubMed Web of Science ®Google Scholar
Johansson JE. The natural course of untreated, localized primary prostate carcinoma Urologe A 1996; 35: 446-8.
PubMedGoogle Scholar
Hugosson J, Aus G, Bergdahl C, Bergdahl S. Prostate cancer mortality in patients surviving more than 10 years after diagnosis. J Urol 1995; 154: 2115-7.
PubMed Web of Science ®Google Scholar
Hugosson J, Aus G. Natural course of localized prostate cancer. A personal view with a review of published papers. Anticancer Res 1997; 17 (Suppl 3A): 1441-8.
PubMed Web of Science ®Google Scholar
Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998; 280: 975-80.
PubMed Web of Science ®Google Scholar
Stamey TA, Johnstone IM, McNeal JE, Lu AY, Yemoto CM. Preoperative serum prostate specific antigen levels between 2 and 22 ng/ml.correlate poorly with postradical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng/ml. J Urol 2002; 167: 103-11.
PubMed Web of Science ®Google Scholar
Zietman AL, Thakral H, Wilson L, Schellhammer P. Conservative management of prostate cancer in the prostate specific antigen era: the incidence and time course of subsequent therapy. J Urol 2001; 166: 1702-6.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Does Initial Surveillance in Early Prostate Cancer Reduce the Chance of Cure by Radical Prostatectomy?: A Case-Control Study

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Does Initial Surveillance in Early Prostate Cancer Reduce the Chance of Cure by Radical Prostatectomy?: A Case-Control Study

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date